COVID-19 Vaccination Supply Chains
Abstract
The ongoing COVID-19 pandemic has severely disrupted supply chains in the United States; the objective of this poster is to provide relevant information to key stakeholders in academia, government, and the general public by providing evidence-based predictive models and risk analytics on the causes and effects posed by COVID-19, on the U.S. trade supply chain infrastructure. The identification and characterization of evidence depicting the dynamics of infrastructure interactions of U.S. domestic and international trade supply chains, from procurement, manufacturing, warehousing, to transportation processes, are expected to derive inferences from public sources of information, and databases following a common risk framework developed by our research group at Texas A&M University.
Subject
COVID-19 (Disease)--Economic aspectsRisk Assessment
COVID-19 (Disease)--Vaccination
Vaccines
Business logistics--United States